Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP683841.RAtxUPu_Z1HaIs3Zg7pwVwuYOVUQI05-acoeuqALz1r2c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP683841.RAtxUPu_Z1HaIs3Zg7pwVwuYOVUQI05-acoeuqALz1r2c130_assertion type Assertion NP683841.RAtxUPu_Z1HaIs3Zg7pwVwuYOVUQI05-acoeuqALz1r2c130_head.
- NP683841.RAtxUPu_Z1HaIs3Zg7pwVwuYOVUQI05-acoeuqALz1r2c130_assertion description "[Allogeneic SCT is important in myelodysplastic syndrome, the BCR-ABL-negative chronic myeloproliferative diseases (CMPDs) and in poor-risk AML.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP683841.RAtxUPu_Z1HaIs3Zg7pwVwuYOVUQI05-acoeuqALz1r2c130_provenance.
- NP683841.RAtxUPu_Z1HaIs3Zg7pwVwuYOVUQI05-acoeuqALz1r2c130_assertion evidence source_evidence_literature NP683841.RAtxUPu_Z1HaIs3Zg7pwVwuYOVUQI05-acoeuqALz1r2c130_provenance.
- NP683841.RAtxUPu_Z1HaIs3Zg7pwVwuYOVUQI05-acoeuqALz1r2c130_assertion SIO_000772 18587431 NP683841.RAtxUPu_Z1HaIs3Zg7pwVwuYOVUQI05-acoeuqALz1r2c130_provenance.
- NP683841.RAtxUPu_Z1HaIs3Zg7pwVwuYOVUQI05-acoeuqALz1r2c130_assertion wasDerivedFrom befree-20150227 NP683841.RAtxUPu_Z1HaIs3Zg7pwVwuYOVUQI05-acoeuqALz1r2c130_provenance.
- NP683841.RAtxUPu_Z1HaIs3Zg7pwVwuYOVUQI05-acoeuqALz1r2c130_assertion wasGeneratedBy ECO_0000203 NP683841.RAtxUPu_Z1HaIs3Zg7pwVwuYOVUQI05-acoeuqALz1r2c130_provenance.